Expert Consensus on the Diagnosis and Management of Digoxin Toxicity
Jason B Hack1, Sue Wingate2, Ron Zolty3
1Brody School of Medicine, East Carolina University, Greenville, Nc.
Despite decreased digoxin use, digoxin toxicity is a persistent clinical issue. Formalized guidance on diagnosis and treatment, including digoxin immune Fab for severe cases, is now available to aid clinicians.
Area of Science:
- Cardiology
- Medical Toxicology
- Clinical Pharmacology
Background:
- Digoxin toxicity presents diagnostic and therapeutic challenges due to its narrow therapeutic window and nonspecific symptoms.
- Despite a decline in digoxin use for heart failure and atrial fibrillation, toxicity remains a significant clinical problem.
Purpose of the Study:
- To develop consensus-based diagnostic and therapeutic guidelines for acute and chronic digoxin toxicity.
- To address clinical uncertainty surrounding digoxin toxicity management.
Main Methods:
- A systematic review of 34,587 publications on digoxin toxicity was conducted, with 114 meeting inclusion criteria.
- 33 consensus statements were developed and evaluated by a modified Delphi process involving expert clinicians.
Main Results:
- Agreement was reached on considering the time and nature of digoxin exposure (acute, chronic).
- Digoxin immune Fab was recommended for life-threatening exposures to reduce mortality risk.
- Several areas requiring further research and clinical attention were identified.
Conclusions:
- Formalized guidance is provided to assist healthcare providers in managing digoxin toxicity.
- This work aims to improve the clinical approach to a persistent challenge in patient care.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
